Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients

Atherosclerosis

Volumn 158, Issue 1, 2001, Pages 233-239

  Szalai, Csaba ^a,b   Duba, Jenö ^c   Prohászka, Zoltán ^a,d   Kalina, Ákos ^e   Szabó, Teréz ^b   Nagy, Bálint ^d   Horváth, Laura ^d   Császár, Albert ^f  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^c National Institute of Cardiology Budapest   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e MAV Hospital   (Hungary)

^f SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Atherosclerosis; Chemokines; Coronary bypass; Lp(a); Polymorphism

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; LIPOPROTEIN A; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; CHEMOKINE CCL2; CHEMOKINES; CHEMOKINES, CXC; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RANTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RISK FACTORS;

EID: 0034898394     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00423-3     Document Type: Article

References (33)

1. Chemokines and leukocyte traffic
2. Chemokines and atherosclerosis
3. The role of MCP-1 in atherosclerosis
4. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression
5. Chemokines and atherosclerosis
6. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES
7. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
8. Chemokines beyond inflammation
9. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant
10. Chemokine receptors and T cell chemotaxis
11. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression
12. The role of CCR5 and CCR2 polymorphism in HIV-1 transmission and disease progression
13. Influence of the CCR2-V64I polymorphism on human immundeficiency virus type 1 coreceptor activity an on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4
14. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
15. Association of CCR5Δ32 with reduced risk of asthma
16. A simple salting out procedure for extracting DNA from human nucleated cells
17. Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin dependent diabetes mellitus
18. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deflcient mice
19. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
20. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E- deficient mice
21. Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants specific IgG autoantibodies and immune complexes
22. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene
23. Lipoprotein(a) as a determinant of coronary heart disease in young women
24. Lipoprotein(a) levels and risk of coronary heart disease in men
25. Elevated lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study
26. Lipoprotein(a) in women twins: Heritability and relationship to apolipoprtein(a) phenotypes
27. Lipoprotein(a) relation to other risk factors and genetic heritability results from a Dutch parent-twin study
28. Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells
29. Lipoprotein(a) is a potent chemoattractant for human peripheral monocytes
30. CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells
31. Local expression of inflammatory cytokines in human atherosclerotic plaques
32. RANTES chemokine expression in transplant-associated accelerated atherosclerosis
33. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1